ArticleScientific reports2025
Surface plasmon enhanced linear and nonlinear optical properties of lycopene bioconjugated silver nanoparticles.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The synthesis of lycopene@silver nanoparticle bioconjugates by pulsed laser ablation in liquid was studied. The ablation product was characterised by UV-Vis optical absorption, Raman spectroscopy and transmission electron microscopy (TEM). The experimental results were confirmed by the computational studies. Furthermore, to assess the influence of the surface plasmon on nonlinear optical (NLO) responses, in this work, we investigated the NLO properties of lycopene@silver systems using the density functional theory (DFT) approach at the M062X/6-311 + G(d,p)/LANL2DZ level. In addition to molecular descriptors, the static and dynamic (at the working wavelengths of the device, 1064 nm and 532 nm) polarizability (α), first hyperpolarizability (β), and second hyperpolarizability (γ) were calculated. Compared to the lycopene molecule, results of the lycopene@Ag
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.